Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Associations of the PON1 rs662 polymorphism with circulating oxidized low-density lipoprotein and lipid levels: a systematic review and meta-analysis.

Luo Z, Pu L, Muhammad I, Chen Y, Sun X.

Lipids Health Dis. 2018 Dec 13;17(1):281. doi: 10.1186/s12944-018-0937-8.

2.

Associations of the PON1 rs854560 polymorphism with plasma lipid levels: a meta-analysis.

Luo Z, Li S, Muhammad I, Karim MR, Song Y.

Lipids Health Dis. 2018 Dec 3;17(1):274. doi: 10.1186/s12944-018-0924-0.

3.

Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis.

Niu C, Luo Z, Yu L, Yang Y, Chen Y, Luo X, Lai F, Song Y.

Lipids Health Dis. 2017 Sep 6;16(1):166. doi: 10.1186/s12944-017-0558-7.

4.

Associations of the MTHFR rs1801133 polymorphism with coronary artery disease and lipid levels: a systematic review and updated meta-analysis.

Luo Z, Lu Z, Muhammad I, Chen Y, Chen Q, Zhang J, Song Y.

Lipids Health Dis. 2018 Aug 17;17(1):191. doi: 10.1186/s12944-018-0837-y. Review.

5.

Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.

Kresanov P, Vasankari T, Ahotupa M, Kaikkonen J, Hutri-Kähönen N, Juonala M, Kähönen M, Lehtimäki T, Viikari J, Raitakari OT.

Atherosclerosis. 2015 Aug;241(2):502-6. doi: 10.1016/j.atherosclerosis.2015.06.004. Epub 2015 Jun 6.

PMID:
26091975
6.

Paraoxonase-1 (PON1) rs662 Polymorphism and Its Association with Serum Lipid Levels and Longevity in the Bama Zhuang Population.

Li Y, Liang G, Shi L, Liang X, Long B, Qin J, Zhang Z.

Med Sci Monit. 2016 Dec 27;22:5154-5162.

7.

Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.

Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, Kumon Y, Hashimoto K.

Metabolism. 2004 Mar;53(3):297-302.

PMID:
15015140
8.

The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials.

Yu L, Zhou C, Luo Z, Zeng W, Lai F, Han G, Song Y.

Lipids Health Dis. 2018 May 10;17(1):106. doi: 10.1186/s12944-018-0760-2.

9.

LDL density and oxidation are modulated by PON1 promoter genotype in patients with Alzheimer's disease.

Cagnin A, Leon A, Vianello D, Colavito D, Favaretto S, Zarantonello G, Stecca A, Ermani M, Zambon A.

J Alzheimers Dis. 2013;34(2):377-85. doi: 10.3233/JAD-121717.

PMID:
23207490
10.

The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis.

Cai G, Zhang B, Shi G, Weng W, Ma C, Song Y, Zhang J.

Lipids Health Dis. 2015 Nov 17;14:149. doi: 10.1186/s12944-015-0154-7.

11.

Associations of the ABCA1 gene polymorphisms with plasma lipid levels: A meta-analysis.

Lu Z, Luo Z, Jia A, Yu L, Muhammad I, Zeng W, Song Y.

Medicine (Baltimore). 2018 Dec;97(50):e13521. doi: 10.1097/MD.0000000000013521. Review.

12.

Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia.

Kim YJ, Park H, Lee HY, Ahn YM, Ha EH, Suh SH, Pang MG.

Eur J Obstet Gynecol Reprod Biol. 2007 Jul;133(1):47-52. Epub 2006 Sep 1.

PMID:
16949193
13.

Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.

Sumegová K, Blazícek P, Waczulíková I, Zitnanová I, Duracková Z.

Acta Biochim Pol. 2006;53(4):783-7. Epub 2006 Nov 14.

14.

What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis.

Qiu C, Zeng P, Li X, Zhang Z, Pan B, Peng ZYF, Li Y, Ma Y, Leng Y, Chen R.

Lipids Health Dis. 2017 Jun 12;16(1):111. doi: 10.1186/s12944-017-0506-6.

15.

Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.

Javadzadeh A, Ghorbanihaghjo A, Bahreini E, Rashtchizadeh N, Argani H, Alizadeh S.

Retina. 2012 Apr;32(4):658-66. doi: 10.1097/IAE.0b013e31822529b1.

PMID:
22030834
16.

Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.

Yıldırım S, Akar S, Kuyucu M, Yıldırım A, Dane S, Aygül R.

Cell Biochem Funct. 2011 Oct;29(7):549-54. doi: 10.1002/cbf.1785. Epub 2011 Jul 14.

PMID:
21755523
17.

Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis.

Song Y, Zhu L, Richa M, Li P, Yang Y, Li S.

Lipids Health Dis. 2015 Apr 18;14:32. doi: 10.1186/s12944-015-0027-0.

18.

High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.

Rodríguez-Carrio J, Alperi-López M, López P, López-Mejías R, Alonso-Castro S, Abal F, Ballina-García FJ, González-Gay MÁ, Suárez A.

J Clin Lipidol. 2017 Jul - Aug;11(4):1043-1054.e2. doi: 10.1016/j.jacl.2017.05.009. Epub 2017 Jun 3.

PMID:
28662934
19.

Interaction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese population.

Han Y, Dorajoo R, Ke T, Ayala B, Chang X, Khor CC, van Dam RM, Yuan JM, Koh WP, Liu J, Goh DY, Friedlander Y, Heng CK.

Atherosclerosis. 2015 May;240(1):40-5. doi: 10.1016/j.atherosclerosis.2015.01.042. Epub 2015 Feb 25.

20.

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.

Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J.

Lancet. 2010 May 8;375(9726):1634-9. doi: 10.1016/S0140-6736(10)60545-4. Erratum in: Lancet. 2010 Jul 10;376(9735):90. Kastelein, J J [added].

Supplemental Content

Support Center